Patents by Inventor Vernon G. Wong

Vernon G. Wong has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • SUSTAINED RELEASE DEXAMETHASONE FORMULATION
    Publication number: 20230078906
    Abstract: The present embodiments provide for a treatment regimen and use of a short-term sustained release liquid formulation of dexamethasone in citrate, wherein a single administration of a minute dosage form into the anterior chamber of the eye provides for anti-inflammatory therapy following cataract surgery.
    Type: Application
    Filed: September 20, 2022
    Publication date: March 16, 2023
    Inventors: Vernon G. WONG, William S. WHITE, Mae W. HU, Glenn T. HUANG, Faina KARASINA
  • Eye drop formulation and method for sustained delivery of medicament to the retina
    Patent number: 11497710
    Abstract: The present embodiments provide compositions, methods and kits for the treatment of ocular conditions or maladies affecting the back of the eye, e.g., the retina.
    Type: Grant
    Filed: June 23, 2020
    Date of Patent: November 15, 2022
    Assignee: CHIBI, INC.
    Inventors: Vernon G. Wong, Glenn T. Huang
  • LIQUID DEPOT FOR NON-INVASIVE SUSTAINED DELIVERY OF AGENTS TO THE EYE
    Publication number: 20220168219
    Abstract: The present embodiments provide compositions, methods, and kits for the treatment or prevention of ocular conditions or maladies via non-invasive liquid depots. In at least one embodiment, the liquid depot is capable of sustained-release delivery of at least one pharmaceutical agent to the eye for days or weeks.
    Type: Application
    Filed: December 9, 2021
    Publication date: June 2, 2022
    Applicant: CHIBI, INC.
    Inventors: VERNON G. WONG, GLENN T. HUANG
  • Liquid depot for non-invasive sustained delivery of agents to the eye
    Patent number: 11234926
    Abstract: The present embodiments provide compositions, methods, and kits for the treatment or prevention of ocular conditions or maladies via non-invasive liquid depots. In at least one embodiment, the liquid depot is capable of sustained-release delivery of at least one pharmaceutical agent to the eye for days or weeks.
    Type: Grant
    Filed: June 23, 2020
    Date of Patent: February 1, 2022
    Assignee: CHIBI, INC.
    Inventors: Vernon G. Wong, Glenn T. Huang
  • DOSE GUIDES FOR INJECTION SYRINGE
    Publication number: 20200384203
    Abstract: The present embodiments provide for simple devices that guide the loading and dispensing of accurate small doses of fluid from standard injection syringes.
    Type: Application
    Filed: August 26, 2020
    Publication date: December 10, 2020
    Applicant: ICON BIOSCIENCE, INC.
    Inventors: Vernon G. WONG, Tan PHAM, William S. WHITE, Glenn T. HUANG, Mae W. HU
  • EYE DROP FORMULATION AND METHOD FOR SUSTAINED DELIVERY OF MEDICAMENT TO THE RETINA
    Publication number: 20200368153
    Abstract: The present embodiments provide compositions, methods and kits for the treatment of ocular conditions or maladies affecting the back of the eye, e.g., the retina.
    Type: Application
    Filed: June 23, 2020
    Publication date: November 26, 2020
    Applicant: IDROP, INC.
    Inventors: Vernon G. Wong, Glenn T. Huang
  • LIQUID DEPOT FOR NON-INVASIVE SUSTAINED DELIVERY OF AGENTS TO THE EYE
    Publication number: 20200368152
    Abstract: The present embodiments provide compositions, methods, and kits for the treatment or prevention of ocular conditions or maladies via non-invasive liquid depots. In at least one embodiment, the liquid depot is capable of sustained-release delivery of at least one pharmaceutical agent to the eye for days or weeks.
    Type: Application
    Filed: June 23, 2020
    Publication date: November 26, 2020
    Applicant: IDROP , INC.
    Inventors: Vernon G. Wong, Glenn T. Huang
  • Dose guides for injection syringe
    Patent number: 10799642
    Abstract: The present embodiments provide for simple devices that guide the loading and dispensing of accurate small doses of fluid from standard injection syringes.
    Type: Grant
    Filed: June 19, 2018
    Date of Patent: October 13, 2020
    Assignee: ICON BIOSCIENCE, INC.
    Inventors: Vernon G. Wong, Tan Pham, William S. White, Glenn T. Huang, Mae W. Hu
  • Sustained release eye drop formulations
    Patent number: 10744202
    Abstract: This invention provides for biocompatible, biodegradable eye drop pharmaceutical formulations useful for the treatment of ocular indications. In particular, tocopherols and their esters of low water solubility, notably ?-tocopheryl acetate, are exceptional vehicles for biocompatible, nonirritating topical eye drop formulations that provide sustained release of active agents.
    Type: Grant
    Filed: June 11, 2018
    Date of Patent: August 18, 2020
    Assignee: Ramscor, Inc.
    Inventors: Vernon G. Wong, Louis L. Wood
  • SUSTAINED RELEASE DEXAMETHASONE FORMULATION
    Publication number: 20190105330
    Abstract: The present embodiments provide for a treatment regimen and use of a short-term sustained release liquid formulation of dexamethasone in citrate, wherein a single administration of a minute dosage form into the anterior chamber of the eye provides for anti-inflammatory therapy following cataract surgery
    Type: Application
    Filed: December 10, 2018
    Publication date: April 11, 2019
    Inventors: Vernon G. WONG, William S. WHITE, Mae W. HU, Glenn T. HUANG, Faina KARASINA
  • Implants and methods for treating inflammation-mediated conditions of the eye
    Patent number: 10206934
    Abstract: Methods for treating inflammation-mediated conditions of the eye are described, comprising: implanting into the vitreous of the eye of an individual a bioerodible implant comprising a steroidal anti-inflammatory agent and a bioerodible polymer, wherein the implant delivers the agent to the vitreous in an amount sufficient to reach a concentration equivalent to at least about 0.05 ?g/ml dexamethasone within about 48 hours and maintains a concentration equivalent to at least about 0.03 ?g/ml dexamethasone for at least about three weeks.
    Type: Grant
    Filed: October 2, 2017
    Date of Patent: February 19, 2019
    Assignee: Allergan, Inc.
    Inventors: Vernon G. Wong, Mae W. L. Hu
  • Use of sustained release dexamethasone in post-cataract surgery inflammation
    Patent number: 10159683
    Abstract: The present embodiments provide for a treatment regimen and use of a short-term sustained release liquid formulation of dexamethasone in citrate, wherein a single administration of a minute dosage form into the anterior chamber of the eye provides for anti-inflammatory therapy following cataract surgery.
    Type: Grant
    Filed: June 26, 2018
    Date of Patent: December 25, 2018
    Assignee: ICON BIOSCIENCE, INC.
    Inventors: Vernon G. Wong, William S. White, Mae W. Hu, Glenn T. Huang, Faina Karasina
  • USE OF SUSTAINED RELEASE DEXAMETHASONE IN POST-CATARACT SURGERY INFLAMMATION
    Publication number: 20180303851
    Abstract: The present embodiments provide for a treatment regimen and use of a short-term sustained release liquid formulation of dexamethasone in citrate, wherein a single administration of a minute dosage form into the anterior chamber of the eye provides for anti-inflammatory therapy following cataract surgery
    Type: Application
    Filed: June 26, 2018
    Publication date: October 25, 2018
    Inventors: Vernon G. WONG, William S. WHITE, Mae W. HU, Glenn T. HUANG, Faina KARASINA
  • DOSE GUIDES FOR INJECTION SYRINGE
    Publication number: 20180296765
    Abstract: The present embodiments provide for simple devices that guide the loading and dispensing of accurate small doses of fluid from standard injection syringes.
    Type: Application
    Filed: June 19, 2018
    Publication date: October 18, 2018
    Inventors: Vernon G. WONG, Tan PHAM, William S. WHITE, Glenn T. HUANG, Mae W. HU
  • SUSTAINED RELEASE EYE DROP FORMULATIONS
    Publication number: 20180289810
    Abstract: This invention provides for biocompatible, biodegradable eye drop pharmaceutical formulations useful for the treatment of ocular indications. In particular, tocopherols and their esters of low water solubility, notably ?-tocopheryl acetate, are exceptional vehicles for biocompatible, nonirritating topical eye drop formulations that provide sustained release of active agents.
    Type: Application
    Filed: June 11, 2018
    Publication date: October 11, 2018
    Applicant: Ramscor, Inc.
    Inventors: Vernon G. Wong, Louis L. Wood
  • CONVENIENTLY IMPLANTABLE SUSTAINED RELEASE DRUG COMPOSITIONS
    Publication number: 20180228898
    Abstract: This invention provides for biocompatible and biodegradable syringeable liquid, implantable solid, and injectable gel pharmaceutical formulations useful for the treatment of systemic and local disease states.
    Type: Application
    Filed: March 28, 2018
    Publication date: August 16, 2018
    Applicant: Ramscor, Inc.
    Inventors: Vernon G. Wong, Louis L. Wood
  • Use of sustained release dexamethasone in post-cataract surgery inflammation
    Patent number: 10028965
    Abstract: The present embodiments provide for a treatment regimen and use of a short-term sustained release liquid formulation of dexamethasone in citrate, wherein a single administration of a minute dosage form into the anterior chamber of the eye provides for anti-inflammatory therapy following cataract surgery.
    Type: Grant
    Filed: May 23, 2014
    Date of Patent: July 24, 2018
    Assignee: ICON BIOSCIENCE, INC.
    Inventors: Vernon G. Wong, William S. White, Mae W. Hu, Glenn T. Huang, Faina Karasina
  • Dose guides for injection syringe
    Patent number: 10022502
    Abstract: Devices that guide the accurate loading and dispensing of predetermined doses of fluid from injection syringes are disclosed.
    Type: Grant
    Filed: April 25, 2012
    Date of Patent: July 17, 2018
    Assignee: ICON BIOSCIENCE, INC.
    Inventors: Vernon G. Wong, Tan Pham, William S. White, Glenn T. Huang, Mae W. Hu
  • Sustained release eye drop formulations
    Patent number: 9993558
    Abstract: This invention provides for biocompatible, biodegradable eye drop pharmaceutical formulations useful for the treatment of ocular indications. In particular, tocopherols and their esters of low water solubility, notably ?-tocopheryl acetate, are exceptional vehicles for biocompatible, nonirritating topical eye drop formulations that provide sustained release of active agents.
    Type: Grant
    Filed: August 9, 2013
    Date of Patent: June 12, 2018
    Assignee: Ramscor, Inc.
    Inventors: Vernon G. Wong, Louis L. Wood
  • IMPLANTS AND METHODS FOR TREATING INFLAMMATION-MEDIATED CONDITIONS OF THE EYE
    Publication number: 20180021352
    Abstract: Methods for treating inflammation-mediated conditions of the eye are described, comprising: implanting into the vitreous of the eye of an individual a bioerodible implant comprising a steroidal anti-inflammatory agent and a bioerodihle polymer, wherein the implant delivers the agent to the vitreous in an amount sufficient to reach a concentration equivalent to at least about 0.05 ?g/ml dexamethasone within about 48 hours and maintains a concentration equivalent to at least about 0.03 ?g/ml dexamethasone for at least about three weeks.
    Type: Application
    Filed: October 2, 2017
    Publication date: January 25, 2018
    Inventors: Vernon G. Wong, Mae W.L. Hu